(PRLB) Proto Labs - Overview
Sector: Industrials | Industry: Metal Fabrication | Exchange: NYSE (USA) | Market Cap: 1.690m USD | Total Return: 90.6% in 12m
Avg Turnover: 11.8M
EPS Trend: 61.1%
Qual. Beats: 4
Rev. Trend: 83.5%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Confidence
Proto Labs, Inc. (PRLB) is a digital manufacturing service provider specializing in the rapid production of custom parts through automated processes. Headquartered in Minnesota, the company utilizes computer numerical control (CNC) machining, injection molding, 3D printing, and sheet metal fabrication to serve engineers and product developers across North America and Europe.
The company operates within the low-volume, high-mix segment of the industrial machinery sector, focusing on speed-to-market for prototypes and end-use production components. By leveraging proprietary software to automate the quoting and manufacturing analysis process, Proto Labs reduces traditional lead times from weeks to days. Investors can explore detailed valuation metrics and historical performance for PRLB on ValueRay.
- Adoption of digital manufacturing services accelerates across diverse industrial engineering sectors
- Growth in the Protolabs Network expands high-volume production and assembly capabilities
- Macroeconomic shifts in industrial R&D spending impact prototyping and low-volume demand
- Raw material cost fluctuations and labor inflation pressure manufacturing gross margins
- Expansion of CNC machining and 3D printing capacity drives revenue scaling potential
| Net Income: 25.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.27 > 1.0 |
| NWC/Revenue: 32.56% < 20% (prev 26.51%; Δ 6.05% < -1%) |
| CFO/TA 0.09 > 3% & CFO 73.7m > Net Income 25.8m |
| Net Debt (-133.7m) to EBITDA (69.5m): -1.92 < 3 |
| Current Ratio: 3.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (24.3m) vs 12m ago -0.61% < -2% |
| Gross Margin: 44.86% > 18% (prev 0.44%; Δ 4.44k% > 0.5%) |
| Asset Turnover: 72.06% > 50% (prev 67.69%; Δ 4.37% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: 0.23 (Total Current Assets 248.6m - Total Current Liabilities 70.7m) / Total Assets 778.6m |
| B: 0.32 (Retained Earnings 248.9m / Total Assets 778.6m) |
| C: 0.05 (EBIT TTM 36.3m / Avg Total Assets 758.0m) |
| D: 2.36 (Book Value of Equity 225.4m / Total Liabilities 95.4m) |
| Altman-Z'' = 5.34 = AAA |
| DSRI: 1.06 (Receivables 86.7m/74.8m, Revenue 546.3m/499.2m) |
| GMI: 0.99 (GM 44.86% / 44.36%) |
| AQI: 0.94 (AQ_t 0.41 / AQ_t-1 0.43) |
| SGI: 1.09 (Revenue 546.3m / 499.2m) |
| TATA: -0.06 (NI 25.8m - CFO 73.7m) / TA 778.6m) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 69.75 with a total of 162,801 shares traded.
Over the past week, the price has changed by -0.90%,
over one month by +11.53%,
over three months by +12.82% and
over the past year by +90.60%.
Proto Labs has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold PRLB.
- StrongBuy: 2
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 75.7 | 8.5% |
P/E Forward = 32.2581
P/S = 3.0935
P/B = 2.4295
P/EG = 0.8585
Revenue TTM = 546.3m USD
EBIT TTM = 36.3m USD
EBITDA TTM = 69.5m USD
Long Term Debt = 1.38m USD (estimated: total debt 2.62m - short term 1.24m)
Short Term Debt = 1.24m USD (from shortTermDebt, last quarter)
Debt = 2.62m USD (from shortLongTermDebtTotal, last quarter) (leases 2.62m already included)
Net Debt = -133.7m USD (calculated: Debt 2.62m - CCE 136.3m)
Enterprise Value = 1.56b USD (1.69b + Debt 2.62m - CCE 136.3m)
Interest Coverage Ratio = unknown (Ebit TTM 36.3m / Interest Expense TTM 0.0)
EV/FCF = 25.15x (Enterprise Value 1.56b / FCF TTM 61.9m)
FCF Yield = 3.98% (FCF TTM 61.9m / Enterprise Value 1.56b)
FCF Margin = 11.33% (FCF TTM 61.9m / Revenue TTM 546.3m)
Net Margin = 4.71% (Net Income TTM 25.8m / Revenue TTM 546.3m)
Gross Margin = 44.86% ((Revenue TTM 546.3m - Cost of Revenue TTM 301.2m) / Revenue TTM)
Gross Margin QoQ = 45.64% (prev 44.23%)
Tobins Q-Ratio = 2.00 (Enterprise Value 1.56b / Total Assets 778.6m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 2.62m)
Taxrate = 28.33% (3.21m / 11.3m)
NOPAT = 26.0m (EBIT 36.3m * (1 - 28.33%))
Current Ratio = 3.51 (Total Current Assets 248.6m / Total Current Liabilities 70.7m)
Debt / Equity = 0.00 (Debt 2.62m / totalStockholderEquity, last quarter 683.1m)
Debt / EBITDA = -1.92 (Net Debt -133.7m / EBITDA 69.5m)
Debt / FCF = -2.16 (Net Debt -133.7m / FCF TTM 61.9m)
Total Stockholder Equity = 670.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.40% (Net Income 25.8m / Total Assets 778.6m)
RoE = 3.84% (Net Income TTM 25.8m / Total Stockholder Equity 670.9m)
RoCE = 5.41% (EBIT 36.3m / Capital Employed (Equity 670.9m + L.T.Debt 1.38m))
RoIC = 4.16% (NOPAT 26.0m / Invested Capital 626.4m)
WACC = 11.53% (E(1.69b)/V(1.69b) * Re(11.55%) + D(2.62m)/V(1.69b) * Rd(0.0%) * (1-Tc(0.28)))
Discount Rate = 11.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.11 | Cagr: -2.80%
[DCF] Terminal Value 62.22% ; FCFF base≈67.3m ; Y1≈59.0m ; Y5≈47.7m
[DCF] Fair Price = 26.79 (EV 503.7m - Net Debt -133.7m = Equity 637.4m / Shares 23.8m; r=11.53% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 61.09 | EPS CAGR: 6.84% | SUE: 4.0 | # QB: 4
Revenue Correlation: 83.54 | Revenue CAGR: 3.03% | SUE: 1.52 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.54 | Chg30d=+15.45% | Revisions=+56% | Analysts=5
EPS next Quarter (2026-09-30): EPS=0.51 | Chg30d=+4.90% | Revisions=+33% | Analysts=5
EPS current Year (2026-12-31): EPS=2.03 | Chg30d=+12.81% | Revisions=+56% | GrowthEPS=+22.1% | GrowthRev=+7.2%
EPS next Year (2027-12-31): EPS=2.21 | Chg30d=+11.35% | Revisions=+50% | GrowthEPS=+9.0% | GrowthRev=+7.0%
[Analyst] Revisions Ratio: +56%